Daiichi Sankyo: Shaping the next decade of oncology growth
What does it take to make billion-dollar decisions in days?
Download the Case Study
Daiichi Sankyo owns the fastest-growing oncology engine in the pharma industry. Within Global Business Development, the Strategic Initiatives team brings a science-forward, capital-informed lens to enterprise decision-making for Daiichi Sankyo’s most senior leadership.
The team’s ADC platform has driven breakout oncology growth, but sustaining that trajectory depends on decisions being made right now. They sought a quantified, peer-grounded analytical foundation to sharpen their strategic planning.
Working with Sleuth, the team built a custom peer database covering 15 peers, 1,550+ assets, and 15 years of deal history. From that one foundation, dozens of analytical cuts traceable to source data and ready for direct use in executive conversations.